PCG Asset Management’s Pfizer PFE Stock Holding History

PCG Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Sell	10,607 -150	-1%	-$3.92K	0.18%	76
2026 Q1	$302K	Sell	10,757 -300	-3%	-$7.99K	0.24%	67
2025 Q4	$286K	Sell	11,057 -100	-0.9%	-$2.52K	0.23%	65
2025 Q3	$284K	Sell	11,157 -1,025	-8%	-$25.3K	0.23%	66
2025 Q2	$295K	Buy	12,182 +2,225	+22%	+$51.9K	0.25%	65
2025 Q1	$252K	Sell	9,957 -575	-5%	-$15K	0.24%	68
2024 Q4	$279K	Buy	+10,532	New	+$286K	0.25%	67

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PCG Asset Management's PFE Position: Q2 2026 in Review

PCG Asset Management reduced its Pfizer (PFE) stake by 1.4% in Q2 2026, selling an estimated $3.92K and leaving 10,607 shares worth $255K. The position accounts for 0.18% of the portfolio, ranked #76.

PCG Asset Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $302K in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

PCG Asset Management held 10,607 shares of Pfizer worth $255K as of Q2 2026.
PCG Asset Management sold 150 Pfizer shares in Q2 2026, an estimated $3.92K.
Pfizer made up 0.18% of PCG Asset Management's portfolio in Q2 2026, its #76 holding.
PCG Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
PCG Asset Management's Pfizer position peaked at $302K in Q1 2026.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PCG Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.